activity can lower the risk of heart failure, confirming the efficacy of beta-blocker therapies. 3. Developmental Biology Roles

While commonly used for heart conditions, beta-blockers have been found to act as proinflammatory agents in the brain, with research in PMC7686098 indicating that they impair microglia-mediated phagocytosis of synaptic material, increasing neuroinflammation. Chronic Heart Failure (CHF): β1beta sub 1

-ARs are enriched in specialized zones with scaffold proteins (SAP97, AKAP79/150), while β2beta sub 2

Generate 0.1904 s 429

Beta-adrenergic: Receptor

activity can lower the risk of heart failure, confirming the efficacy of beta-blocker therapies. 3. Developmental Biology Roles

While commonly used for heart conditions, beta-blockers have been found to act as proinflammatory agents in the brain, with research in PMC7686098 indicating that they impair microglia-mediated phagocytosis of synaptic material, increasing neuroinflammation. Chronic Heart Failure (CHF): β1beta sub 1

-ARs are enriched in specialized zones with scaffold proteins (SAP97, AKAP79/150), while β2beta sub 2

});